{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:42:16Z","timestamp":1778776936024,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.waojou.2019.100019","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T14:33:29Z","timestamp":1552574009000},"page":"100019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["State of care for patients with systemic autoinflammatory diseases \u2013 Results of a tertiary care survey"],"prefix":"10.1016","volume":"12","author":[{"given":"Mati","family":"Chuamanochan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin","family":"K\u00fcmmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.waojou.2019.100019_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrrheum.2013.101","article-title":"How should we approach classification of autoinflammatory diseases?","volume":"9","author":"Grateau","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.waojou.2019.100019_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.det.2013.05.001","article-title":"Autoinflammatory syndromes","volume":"31","author":"Cush","year":"2013","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.waojou.2019.100019_bib3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.waojou.2019.100019_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/all.13035","article-title":"Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients","volume":"72","author":"Gusdorf","year":"2017","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.waojou.2019.100019_bib5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","article-title":"Familial Mediterranean fever, review of the literature","volume":"36","author":"Alghamdi","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.waojou.2019.100019_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial mediterranean Fever in the world","volume":"61","author":"Ben-Chetrit","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.waojou.2019.100019_bib7","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00431-012-1803-8","article-title":"Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population","volume":"171","author":"Lainka","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1016\/j.waojou.2019.100019_bib8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","volume":"71","author":"Toplak","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/rheumatology\/keq270","article-title":"Translational research network and patient registry for auto-inflammatory diseases","volume":"50","author":"Lainka","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"10.1016\/j.waojou.2019.100019_bib10","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.waojou.2019.100019_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/annrheumdis-2014-206580","article-title":"Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers","volume":"74","author":"Federici","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.waojou.2019.100019_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.waojou.2019.100019_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.waojou.2019.100019_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler's syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2019.100019_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.clindermatol.2015.05.002","article-title":"Cutaneous manifestations of systemic autoinflammatory disorders","volume":"33","author":"Bolukbasi","year":"2015","journal-title":"Clin Dermatol"},{"issue":"9","key":"10.1016\/j.waojou.2019.100019_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.waojou.2019.100019_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.semarthrit.2013.04.011","article-title":"Evidence-based recommendations for the practical management of familial mediterranean fever","volume":"43","author":"Hentgen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.waojou.2019.100019_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"10","key":"10.1016\/j.waojou.2019.100019_bib19","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"Ringold","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.waojou.2019.100019_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.waojou.2019.100019_bib21","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Behcet disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.waojou.2019.100019_bib22","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","article-title":"Management of Behcet disease: a systematic literature review for the European League against Rheumatism evidence-based recommendations for the management of Behcet disease","volume":"68","author":"Hatemi","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","article-title":"A\u00a0web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry","volume":"12","author":"Papa","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.waojou.2019.100019_bib24","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.waojou.2019.100019_bib25","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of Mevalonate kinase deficiency: a series of 114 cases from the eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.waojou.2019.100019_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0033-1355372","article-title":"Genotype-phenotype and genotype-origin correlations in children with mediterranean fever in Germany - an AID-net study","volume":"225","author":"Jeske","year":"2013","journal-title":"Klin P\u00e4diatr"},{"issue":"12","key":"10.1016\/j.waojou.2019.100019_bib27","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1136\/annrheumdis-2013-203666","article-title":"Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes","volume":"73","author":"Piram","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.waojou.2019.100019_bib28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","article-title":"Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study","volume":"139","author":"Krause","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2019.100019_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.waojou.2019.100019_bib30","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar4237","article-title":"Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens","volume":"15","author":"Kuemmerle-Deschner","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.waojou.2019.100019_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/annrheumdis-2016-210092","article-title":"Development of the autoinflammatory disease damage index (ADDI)","volume":"76","author":"Ter Haar","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl 102","key":"10.1016\/j.waojou.2019.100019_bib32","first-page":"129","article-title":"A\u00a0novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment report","volume":"34","author":"Konukbay","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"20","key":"10.1016\/j.waojou.2019.100019_bib33","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.waojou.2019.100019_bib34","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.waojou.2019.100019_bib35","first-page":"2134","article-title":"Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies","volume":"54","author":"Cavalli","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl_1","key":"10.1016\/j.waojou.2019.100019_bib36","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on colchicine, 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.waojou.2019.100019_bib37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-81-6-792","article-title":"Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study","volume":"81","author":"Goldstein","year":"1974","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.waojou.2019.100019_bib38","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial mediterranean fever. A double-blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.rbr.2015.08.007","article-title":"Guidelines for the management and treatment of periodic fever syndromes: cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS)","volume":"56","author":"Terreri","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"4","key":"10.1016\/j.waojou.2019.100019_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.waojou.2019.100019_bib41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.rbr.2015.08.006","article-title":"Guidelines for the management and treatment of periodic fever syndromes familial Mediterranean fever","volume":"56","author":"Terreri","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"10.1016\/j.waojou.2019.100019_bib43","first-page":"1","article-title":"Evidence-based clinical practice guideline for adult Still's disease","author":"Mimura","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-018-0224-2","article-title":"Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany","volume":"16","author":"Hinze","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.waojou.2019.100019_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.waojou.2019.100019_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-9-16","article-title":"Evidence-based practice in Behcet's disease: identifying areas of unmet need for 2014","volume":"9","author":"Barry","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.waojou.2019.100019_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/08916934.2018.1442442","article-title":"Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome","volume":"51","author":"McDonald","year":"2018","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.waojou.2019.100019_bib48","doi-asserted-by":"crossref","first-page":"365 e13","DOI":"10.1016\/j.amjmed.2016.09.028","article-title":"A\u00a0systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease","volume":"130","author":"Yao","year":"2017","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.waojou.2019.100019_bib49","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s10067-016-3410-y","article-title":"NLRP12 autoinflammatory disease: a Chinese case series and literature review","volume":"36","author":"Shen","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100019_bib50","first-page":"328","article-title":"[Clinical aspects and genetics of proteasome-associated autoinflammatory syndromes (PRAAS)]","volume":"76","author":"Feist","year":"2017","journal-title":"Z\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1468-3083.2011.04370.x","article-title":"Management of chronic spontaneous urticaria in real life--in accordance with the guidelines? A cross-sectional physician-based survey study","volume":"27","author":"Weller","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100019_bib52","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/j.1468-3083.2011.04387.x","article-title":"Selected urticaria patients benefit from a referral to tertiary care centres--results of an expert survey","volume":"27","author":"Weller","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119301073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119301073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T07:41:42Z","timestamp":1565163702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119301073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["S1939455119301073"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100019","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State of care for patients with systemic autoinflammatory diseases \u2013 Results of a tertiary care survey","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100019"}}